Apnimed, Inc. (APMD) vs Faeth Therapeutics, Inc. (FTH)
A side-by-side comparison of Apnimed, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APMD
Apnimed, Inc.
$18.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
FTH
Faeth Therapeutics, Inc.
$26.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — APMD vs FTH
growth of $100 · dividends reinvested · last 1yAPMD +35.9% (+35.9%/yr)FTH -7.0% (-7.0%/yr)APMD compounded faster over this window
APMD FTH
Metrics side by side
Total return (annualized)
| Metric | APMD | FTH |
|---|---|---|
| Total return (1Y) | N/A | 182.36% |
| Total return CAGR (3Y) | N/A | 23.46% |
| Total return CAGR (5Y) | N/A | -31.75% |
APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.